Migraine Research in Phoenix: What to Know About Observational Studies

SEO title: Migraine Research in Phoenix: What to Know About Observational Studies
Suggested slug: migraine-research-phoenix-observational-study
Focus keyphrase: migraine research in Phoenix
Meta description: Learn how observational migraine research works in Phoenix, what participation may involve, and how to ask about current Arizona Neuroscience Research studies.

Living with migraine often means learning to plan around a condition that can interrupt work, family time, sleep, and the routines that make a day feel manageable. For adults in Phoenix and across Arizona who are interested in clinical research, a common question is simple: what does it actually mean to take part in a migraine study?

Arizona Neuroscience Research is currently listing the PHASES (P25-590) observational migraine study among its current studies. The study is evaluating real-world changes in migraine attack severity among adults who use oral ubrogepant as part of their regular care. This article explains what an observational study is, what questions to ask before volunteering, and why an initial screening conversation matters. It is educational information, not medical advice, and it does not guarantee that someone will qualify or benefit from a study.

Why migraine research matters in Arizona

Migraine is more than a headache. It is a neurological condition that may involve throbbing or pulsing head pain, nausea, sensitivity to light or sound, visual symptoms, dizziness, fatigue, or difficulty thinking clearly. Symptoms and patterns vary widely. Some people have occasional attacks, while others experience symptoms often enough to affect employment, relationships, or daily activities.

Research helps clinicians, sponsors, and the broader medical community understand how migraine affects people in everyday life. Studies may examine new treatments, established treatments, safety, practical treatment patterns, questionnaires, symptom diaries, or the experiences people report over time. Arizona participation matters because research should reflect the communities who may ultimately use the information it produces.

For someone considering a study, the goal is not to assume that research is the right choice. The goal is to gather clear information, weigh the commitment, and decide whether a screening conversation makes sense.

What is an observational migraine study?

Clinical research comes in different forms. In an interventional trial, a study protocol may assign participants to an investigational treatment, comparison treatment, or placebo. An observational study takes a different approach. It generally follows people receiving care in the usual setting and records information about outcomes, symptoms, safety, or treatment use.

For the PHASES P25-590 study listed by Arizona Neuroscience Research, the sponsor describes an observational study of adult participants who are already prescribed ubrogepant for acute migraine treatment according to routine clinical practice and the local product label. The study is intended to assess changes in migraine attack severity when treatment is used during the prodrome phase of migraine attacks. “Prodrome” refers to early symptoms that can occur before head pain in some people, such as unusual fatigue, mood changes, neck discomfort, food cravings, or trouble concentrating. Not everyone has a prodrome, and people should never change when or how they take a medication without direction from their treating clinician.

Observational does not mean casual. A study still has a protocol, eligibility criteria, consent process, privacy procedures, and defined information that the research team collects. It also does not mean that a person will be enrolled simply because they have migraine or take a particular medicine. Screening is used to determine whether the study’s requirements fit an individual’s situation.

What the study is and is not designed to do

• It is designed to collect structured information about migraine experiences in a defined group of adults.
• It may involve visits, questionnaires, electronic diaries, or follow-up that are described during screening and consent.
• It is not a promise that a person’s migraines will improve.
• It is not a replacement for individualized medical care or emergency evaluation.
• It is not a reason to start, stop, or adjust a medication without a prescriber’s guidance.

Who may want to ask about the PHASES study?

The most useful first step is a conversation with the research team. Arizona Neuroscience Research’s current-study listing says that PHASES P25-590 is evaluating adults with migraine who use ubrogepant. The sponsor’s study page describes adults with a current diagnosis of migraine or chronic migraine who are currently prescribed ubrogepant and have used it for acute migraine treatment for at least three months. The sponsor also lists other requirements and exclusions. Those details can change, and only the site’s screening process can determine eligibility.

Someone may consider asking for information if they are an adult with migraine, use a prescribed acute migraine treatment, and are interested in learning how migraine patterns are studied outside of a traditional treatment-assignment trial. A conversation is appropriate even when a person is uncertain. It is also appropriate to decide that the timing, travel, study tasks, or other requirements are not a good fit.

What happens before someone joins a research study?

Research participation begins with information, not a commitment. A typical process includes an initial contact, a prescreening discussion, a review of study-specific eligibility questions, and an informed-consent conversation if the study team believes the person may qualify. The steps vary by protocol.

Initial contact and prescreening

During a first call or form submission, a coordinator may ask general questions about age, migraine history, current care, and availability. The purpose is to see whether it makes sense to schedule a more detailed review. It is helpful to have a list of current medications, the name of the clinician who manages migraine care, and a general sense of how often migraine days occur. Do not share more personal information than the research team requests through its official contact process.

Informed consent

Informed consent is a process, not merely a signature. The research team should explain the study purpose, procedures, anticipated time commitment, possible risks or discomforts, privacy practices, alternatives, compensation or reimbursement if applicable, and whom to contact with questions. Participants should have time to read the consent form and ask questions. They may choose not to enroll, and they may withdraw from a study as described in the consent materials.

Screening does not guarantee enrollment

A person can complete some screening steps and still not qualify. That outcome is common in research and does not mean that someone did anything wrong. Protocols are designed to answer specific scientific questions, so they include detailed criteria. The team may also pause or close enrollment when a study reaches its planned number of participants.

Questions to ask before volunteering

Good questions make it easier to decide whether a study fits your needs. Consider writing down the answers or bringing a support person to the conversation when permitted.

• What is the purpose of this study, and what information will it collect?
• Is this observational, or does it involve an investigational treatment or assignment to a study group?
• What visits, diaries, surveys, laboratory work, or other activities are required?
• How long will participation last, and are any visits remote?
• Will I continue receiving my routine clinical care?
• What are the possible risks, discomforts, and benefits?
• What happens if my migraine pattern changes during the study?
• How will my information be protected?
• Are travel reimbursement, parking, compensation, or study-related services available? If so, what are the exact terms?
• Who should I contact after hours or if I have a research-related question?

Keeping a migraine record can support a useful conversation

A migraine diary is not required for every research inquiry, but it can make it easier to describe what is happening. A simple record may include the date of symptoms, early warning signs, time pain began, associated symptoms, possible triggers, acute treatments used, and how the attack affected regular activities. The diary should support a conversation with a clinician or research coordinator; it should not be used to self-diagnose or self-manage a new or concerning symptom.

People sometimes worry that their patterns are “not consistent enough” to discuss. Real-world migraine patterns can be messy. The important thing is to describe symptoms honestly and to avoid changing medications or routines solely to meet an imagined study requirement.

Research participation and regular medical care

Clinical research is not a substitute for medical care. If you already work with a neurologist, primary care clinician, or headache specialist, continue following their guidance. The study team can explain whether a particular protocol allows concurrent care and which records or medication information may be needed. A research coordinator cannot tell someone to disregard advice from their own treating clinician.

For the PHASES study, the sponsor indicates that participants use ubrogepant as prescribed by their clinician in routine practice. That distinction is important. Study participation does not establish whether a medicine is appropriate for any particular person. Medication decisions, contraindications, interactions, and dosing questions require a conversation with a licensed clinician who knows the person’s medical history.

When migraine symptoms need urgent attention

Most migraine attacks do not require emergency care, but certain symptoms should be evaluated urgently. Seek emergency help for a sudden, severe headache that reaches maximum intensity quickly; a new headache after significant head injury; new weakness, facial droop, speech difficulty, fainting, seizure, confusion, vision loss, chest pain, or severe shortness of breath; fever with stiff neck; or a headache that feels clearly different from prior attacks. In Arizona, call 911 or seek emergency evaluation when symptoms may represent a stroke or another emergency. Do not wait for a research appointment to assess urgent symptoms.

How to learn about current Arizona studies

Study availability changes. The most accurate local source is the Arizona Neuroscience Research Current Studies page. Adults interested in volunteering can also use the Volunteer Today page to request information from the research team. For independent details about PHASES P25-590, review the sponsor’s official study page and the current registry information before making a decision.

Arizona Neuroscience Research has Phoenix locations at 3805 E. Bell Rd., Suite 2400 and 4400 N. 32nd St., Suite 150. The research team can explain which location, if any, is relevant for a specific study and whether enrollment is currently open.

Frequently asked questions

Will I receive a new migraine medication if I join?

Not necessarily. The PHASES study is described as observational and follows adults using ubrogepant as prescribed in routine care. Study details differ, so ask the research team what a particular protocol provides and what it does not provide.

Can I join if I have chronic migraine?

The sponsor’s current page includes adults with migraine or chronic migraine under specific conditions, but eligibility is determined only through formal screening. Contact Arizona Neuroscience Research for the current local criteria.

Will participation cure my migraine?

No study can promise a cure, symptom relief, enrollment, or an individual outcome. Research may help generate information that supports future care, but each person’s experience is different.

Do I need to live in Phoenix?

Ask the team about travel, visit locations, remote components, and requirements. Some study tasks may be remote, while others may require in-person visits.

Can I leave a study after enrolling?

Participation is voluntary. The consent process explains withdrawal options, safety follow-up, and any steps to take if you decide to stop.

A thoughtful next step

For Arizona adults living with migraine, clinical research can be a chance to learn how studies work and whether a current protocol fits their circumstances. Start with accurate information, ask direct questions, and keep regular medical care at the center of your decision-making.

To ask about the current PHASES P25-590 observational migraine study or other research opportunities, visit Current Studies or submit a request through Volunteer Today. The Arizona Neuroscience Research team can explain current availability and the next screening step.

Educational disclaimer: This article provides general information about clinical research and migraine. It is not medical advice, does not establish a patient-provider relationship, and does not guarantee study eligibility, enrollment, treatment access, or individual benefit. Discuss personal medical questions with a qualified clinician. For emergency symptoms, call 911 or seek emergency care.